Literature DB >> 29150566

The Loss of TET2 Promotes CD8+ T Cell Memory Differentiation.

Shannon A Carty1, Mercy Gohil2, Lauren B Banks2, Renee M Cotton3, Matthew E Johnson4, Erietta Stelekati5,6, Andrew D Wells3,4,6, E John Wherry5,6, Gary A Koretzky7,8, Martha S Jordan9,6.   

Abstract

T cell differentiation requires appropriate regulation of DNA methylation. In this article, we demonstrate that the methylcytosine dioxygenase ten-eleven translocation (TET)2 regulates CD8+ T cell differentiation. In a murine model of acute viral infection, TET2 loss promotes early acquisition of a memory CD8+ T cell fate in a cell-intrinsic manner without disrupting Ag-driven cell expansion or effector function. Upon secondary recall, TET2-deficient memory CD8+ T cells demonstrate superior pathogen control. Genome-wide methylation analysis identified a number of differentially methylated regions in TET2-deficient versus wild-type CD8+ T cells. These differentially methylated regions did not occur at the loci of differentially expressed memory markers; rather, several hypermethylated regions were identified in known transcriptional regulators of CD8+ T cell memory fate. Together, these data demonstrate that TET2 is an important regulator of CD8+ T cell fate decisions.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29150566      PMCID: PMC5736442          DOI: 10.4049/jimmunol.1700559

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

1.  TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity.

Authors:  Kristine Williams; Jesper Christensen; Marianne Terndrup Pedersen; Jens V Johansen; Paul A C Cloos; Juri Rappsilber; Kristian Helin
Journal:  Nature       Date:  2011-04-13       Impact factor: 49.962

2.  Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells.

Authors:  Chance John Luckey; Deepta Bhattacharya; Ananda W Goldrath; Irving L Weissman; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

3.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

4.  Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation.

Authors:  Brendan E Russ; Moshe Olshanksy; Heather S Smallwood; Jasmine Li; Alice E Denton; Julia E Prier; Angus T Stock; Hayley A Croom; Jolie G Cullen; Michelle L T Nguyen; Stephanie Rowe; Matthew R Olson; David B Finkelstein; Anne Kelso; Paul G Thomas; Terry P Speed; Sudha Rao; Stephen J Turner
Journal:  Immunity       Date:  2014-11-06       Impact factor: 31.745

5.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells.

Authors:  Gang Wei; Lai Wei; Jinfang Zhu; Chongzhi Zang; Jane Hu-Li; Zhengju Yao; Kairong Cui; Yuka Kanno; Tae-Young Roh; Wendy T Watford; Dustin E Schones; Weiqun Peng; Hong-Wei Sun; William E Paul; John J O'Shea; Keji Zhao
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

6.  Control of Foxp3 stability through modulation of TET activity.

Authors:  Xiaojing Yue; Sara Trifari; Tarmo Äijö; Ageliki Tsagaratou; William A Pastor; Jorge A Zepeda-Martínez; Chan-Wang J Lio; Xiang Li; Yun Huang; Pandurangan Vijayanand; Harri Lähdesmäki; Anjana Rao
Journal:  J Exp Med       Date:  2016-02-22       Impact factor: 14.307

7.  Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis.

Authors:  Kasper D Rasmussen; Guangshuai Jia; Jens V Johansen; Marianne T Pedersen; Nicolas Rapin; Frederik O Bagger; Bo T Porse; Olivier A Bernard; Jesper Christensen; Kristian Helin
Journal:  Genes Dev       Date:  2015-04-17       Impact factor: 11.361

8.  Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells.

Authors:  Kathryn Blaschke; Kevin T Ebata; Mohammad M Karimi; Jorge A Zepeda-Martínez; Preeti Goyal; Sahasransu Mahapatra; Angela Tam; Diana J Laird; Martin Hirst; Anjana Rao; Matthew C Lorincz; Miguel Ramalho-Santos
Journal:  Nature       Date:  2013-06-30       Impact factor: 49.962

9.  Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscape.

Authors:  Joseph G Crompton; Manikandan Narayanan; Suresh Cuddapah; Rahul Roychoudhuri; Yun Ji; Wenjing Yang; Shashank J Patel; Madhusudhanan Sukumar; Douglas C Palmer; Weiqun Peng; Ena Wang; Francesco M Marincola; Christopher A Klebanoff; Keji Zhao; John S Tsang; Luca Gattinoni; Nicholas P Restifo
Journal:  Cell Mol Immunol       Date:  2015-04-27       Impact factor: 11.530

10.  DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells.

Authors:  Xiaotian Zhang; Jianzhong Su; Mira Jeong; Myunggon Ko; Yun Huang; Hyun Jung Park; Anna Guzman; Yong Lei; Yung-Hsin Huang; Anjana Rao; Wei Li; Margaret A Goodell
Journal:  Nat Genet       Date:  2016-07-18       Impact factor: 38.330

View more
  50 in total

1.  Self-Regulation of Memory CD8 T Cell Metabolism through Extracellular ATP Signaling.

Authors:  Kelsey M Wanhainen; Stephen C Jameson; Henrique Borges da Silva
Journal:  Immunometabolism       Date:  2019-07-23

Review 2.  Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies.

Authors:  Chan-Wang J Lio; Hiroshi Yuita; Anjana Rao
Journal:  Blood       Date:  2019-10-31       Impact factor: 22.113

3.  CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration.

Authors:  Christopher L Nobles; Scott Sherrill-Mix; John K Everett; Shantan Reddy; Joseph A Fraietta; David L Porter; Noelle Frey; Saar I Gill; Stephan A Grupp; Shannon L Maude; Donald L Siegel; Bruce L Levine; Carl H June; Simon F Lacey; J Joseph Melenhorst; Frederic D Bushman
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

4.  TET family dioxygenases and the TET activator vitamin C in immune responses and cancer.

Authors:  Xiaojing Yue; Anjana Rao
Journal:  Blood       Date:  2020-09-17       Impact factor: 22.113

Review 5.  Targeting the epigenetic regulation of antitumour immunity.

Authors:  Simon J Hogg; Paul A Beavis; Mark A Dawson; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2020-09-14       Impact factor: 84.694

Review 6.  Circles of Life: linking metabolic and epigenetic cycles to immunity.

Authors:  Chan-Wang Jerry Lio; Stanley Ching-Cheng Huang
Journal:  Immunology       Date:  2020-06-03       Impact factor: 7.397

Review 7.  Brain immunology and immunotherapy in brain tumours.

Authors:  John H Sampson; Michael D Gunn; Peter E Fecci; David M Ashley
Journal:  Nat Rev Cancer       Date:  2019-12-05       Impact factor: 60.716

8.  In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions.

Authors:  Hongling Huang; Peipei Zhou; Jun Wei; Lingyun Long; Hao Shi; Yogesh Dhungana; Nicole M Chapman; Guotong Fu; Jordy Saravia; Jana L Raynor; Shaofeng Liu; Gustavo Palacios; Yong-Dong Wang; Chenxi Qian; Jiyang Yu; Hongbo Chi
Journal:  Cell       Date:  2021-02-25       Impact factor: 41.582

Review 9.  The emerging role of epigenetic therapeutics in immuno-oncology.

Authors:  Michael J Topper; Michelle Vaz; Kristen A Marrone; Julie R Brahmer; Stephen B Baylin
Journal:  Nat Rev Clin Oncol       Date:  2019-09-23       Impact factor: 66.675

Review 10.  Epigenetic control of CD8+ T cell differentiation.

Authors:  Amanda N Henning; Rahul Roychoudhuri; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2018-01-30       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.